Opportunities for Pharmacogenetic Testing Among Hospitalized Children With Medical Complexity
PPIs were the most common CPIC level A medications and are metabolized by CYP2C19, making it the most highly implicated gene. PPI-CYP2C19 should be a PGx testing priority.
Authors
- Addison Donaher
- Kathryn Pavia (ORCID: https://orcid.org/0000-0002-6231-3323)
- Abigail Musial
- Carter McIntire
- Scott Callahan (ORCID: https://orcid.org/0000-0003-3914-7176)
- Sonya Tang Girdwood
- Dakota Skinn
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- Hospital Pediatrics
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1542/hpeds.2025-008751
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00